N
Nanjing Xiyuxun Technology XYX
Request Full Data Access to the PeptideMeter database of peptide tests.
Products
| Product | Rating | Count | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | D | 2 | 4.9 | 4.1 | 5.7 | 20 May 2025 |
| GHK-Cu | X | 1 | 9.8 | 9.8 | 9.8 | 16 Jul 2025 |
| 1-Benzyl-4-piperidone CAS 3612-20-2 | X | 1 | 6.2 | 6.2 | 6.2 | 28 Mar 2025 |
| 4-Piperidone monohydrate hydrochloride CAS 40064-34-4 | X | 1 | 6.5 | 6.5 | 6.5 | 8 Jul 2025 |
| AA Water | X | 1 | 6.6 | 6.6 | 6.6 | 2 Apr 2025 |
| AICAR Oral | X | 1 | 5.7 | 5.7 | 5.7 | 13 Jun 2025 |
| Andarine (S-4) Raw | X | 1 | 4.6 | 4.6 | 4.6 | 13 Feb 2025 |
| ARA-290 | X | 1 | 7.6 | 7.6 | 7.6 | 6 May 2025 |
| BAC Water | X | 1 | 4.3 | 4.3 | 4.3 | 16 Mar 2025 |
| BPC-157 Capsule | X | 1 | 9.3 | 9.3 | 9.3 | 25 Apr 2025 |
| BPC157 5mg + TB500 5mg Blend | X | 1 | 5.3 | 5.3 | 5.3 | 9 Jun 2025 |
| Cardiogen | X | 1 | 7.1 | 7.1 | 7.1 | 25 Apr 2025 |
| Cartalax | X | 1 | 9.4 | 9.4 | 9.4 | 7 May 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X | 1 | 7.0 | 7.0 | 7.0 | 21 May 2025 |
| Deca (Nandrolone Decanoate) | X | 1 | 7.9 | 7.9 | 7.9 | 9 Jun 2025 |
| EPO | X | 1 | 6.9 | 6.9 | 6.9 | 13 Jun 2025 |
| GHRP-2 Acetate | X | 1 | 5.6 | 5.6 | 5.6 | 13 Feb 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X | 1 | 5.4 | 5.4 | 5.4 | 2 Apr 2025 |
| Healthy Hair Skin Nails Blend (Niacinamide+Thiamine+Pantothenic Acid+Choline+Inositol+Niacin+Biotin+Folic Acid+Riboflavin) | X | 1 | 8.2 | 8.2 | 8.2 | 7 May 2025 |
| Humanin | X | 1 | 7.1 | 7.1 | 7.1 | 9 Jun 2025 |
| Lipo-C 120mg | X | 1 | 7.5 | 7.5 | 7.5 | 13 Feb 2025 |
| Liraglutide | X | 1 | 6.7 | 6.7 | 6.7 | 27 Feb 2025 |
| MOTS-C | X | 1 | 4.6 | 4.6 | 4.6 | 21 May 2025 |
| MT-1 | X | 1 | 4.7 | 4.7 | 4.7 | 25 Apr 2025 |
| NA Selank Amidate | X | 1 | 4.0 | 3.7 | 3.7 | 17 Dec 2024 |
| NA Semax Amidate | X | 1 | 6.4 | 6.4 | 6.4 | 27 Feb 2025 |
| NAD+ | X | 1 | 5.8 | 5.8 | 5.8 | 13 Feb 2025 |
| Ovagen | X | 1 | 5.0 | 5.0 | 5.0 | 7 May 2025 |
| PE 22-28 | X | 1 | 7.6 | 7.6 | 7.6 | 2 Jul 2025 |
| PNC 27 | X | 1 | 8.1 | 8.1 | 8.1 | 28 Mar 2025 |
| Prednisone | X | 1 | 7.6 | 7.6 | 7.6 | 21 May 2025 |
| Prostamax | X | 1 | 6.6 | 6.6 | 6.6 | 27 Feb 2025 |
| Proviron (Mesterolone) | X | 1 | 6.8 | 6.8 | 6.8 | 14 Jan 2025 |
| Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | X | 1 | 4.8 | 4.8 | 4.8 | 8 Jul 2025 |
| Selank 10mg + Semax 10mg Blend | X | 1 | 4.0 | 3.1 | 3.1 | 14 Jan 2025 |
| SNAP-8 | X | 1 | 6.0 | 6.0 | 6.0 | 14 Jan 2025 |
| Telmisartan | X | 1 | 5.2 | 5.2 | 5.2 | 21 May 2025 |
| Tirzepatide Oral | X | 1 | 5.6 | 5.6 | 5.6 | 20 Jun 2025 |
| Tren Hex | X | 1 | 4.1 | 4.1 | 4.1 | 13 Jun 2025 |
| Vilon | X | 1 | 5.4 | 5.4 | 5.4 | 24 Apr 2025 |
| Winstrol (Stanozolol) | X | 1 | 7.8 | 7.8 | 7.8 | 24 Apr 2025 |
Test Results
| Date | Product | Score | Expected | Actual | Deviation | Purity | Lab |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | SNAP-8 | 6.5 | 20mg | 24.5mg | +22.7% | 95.23% | Lab A |
| 25 May 2026 | Tren Hex | 4.6 | 200mg/ml | 244.4mg/ml | +22.2% | 96.62% | Lab D |
| 24 May 2026 | Andarine (S-4) Raw | 4.0 | 5g | 5.1g | +1.2% | 97.34% | Lab F |
| 24 May 2026 | GHRP-2 Acetate | 4.6 | 10mg | 10.4mg | +4.0% | 97.97% | Lab B |
| 24 May 2026 | Cardiogen | 7.0 | 2mg | 2.2mg | +8.5% | 95.43% | Lab D |
| 23 May 2026 | Healthy Hair Skin Nails Blend (Niacinamide+Thiamine+Pantothenic Acid+Choline+Inositol+Niacin+Biotin+Folic Acid+Riboflavin) | 7.8 | 200mg/ml | 240.5mg/ml | +20.2% | 95.34% | Lab D |
| 23 May 2026 | EPO | 6.9 | 10mg | 9.3mg | -7.0% | 95.43% | Lab E |
| 21 May 2026 | 4-Piperidone monohydrate hydrochloride CAS 40064-34-4 | 7.3 | 1g | 1.0g | +3.2% | 96.11% | Lab C |
| 21 May 2026 | Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | 4.1 | 100mg/ml | 106.1mg/ml | +6.1% | 97.36% | Lab G |
| 20 May 2026 | BAC Water | 4.0 | 2mg | 1.8mg | -10.6% | 95.04% | Lab C |
| 17 May 2026 | NA Semax Amidate | 7.8 | 30mg | 33.5mg | +11.8% | 97.85% | Lab C |
| 17 May 2026 | Vilon | 4.0 | 20mg | 22.3mg | +11.5% | 95.57% | Lab G |
| 26 Jan 2026 | BPC-157 Capsule | 10.0 | 10mg | 10.6mg | +5.9% | 99.55% | Lab D |
| 26 Jan 2026 | MOTS-C | 4.9 | 2mg | 1.9mg | -2.7% | 98.77% | Lab D |
| 26 Jan 2026 | Ovagen | 4.0 | 5mg | 4.6mg | -7.8% | 97.96% | Lab B |
| 19 Jan 2026 | PE 22-28 | 5.7 | 30mg | 35.6mg | +18.6% | 97.15% | Lab E |
| 7 Jan 2026 | AICAR Oral | 6.3 | 10mg | 12.4mg | +24.3% | 99.34% | Lab G |
| 7 Jan 2026 | NA Selank Amidate | 6.4 | 5mg | 5.3mg | +6.2% | 97.11% | Lab C |
| 7 Jan 2026 | PNC 27 | 8.7 | 10mg | 10.1mg | +0.9% | 96.84% | Lab G |
| 7 Jan 2026 | Prednisone | 6.0 | 100mg | 103.1mg | +3.1% | 95.04% | Lab B |
| 6 Jan 2026 | AA Water | 4.6 | 20mg | 24.6mg | +22.9% | 98.01% | Lab A |
| 6 Jan 2026 | Deca (Nandrolone Decanoate) | 7.7 | 100mg/ml | 102.4mg/ml | +2.4% | 96.41% | Lab C |
| 6 Jan 2026 | Selank 10mg + Semax 10mg Blend | 4.0 | 5mg | 5.6mg | +11.8% | 95.06% | Lab F |
| 29 Dec 2025 | ARA-290 | 7.5 | 20mg | 23.6mg | +17.9% | 95.33% | Lab G |
| 29 Dec 2025 | Cartalax | 10.0 | 2mg | 2.4mg | +21.0% | 96.99% | Lab E |
| 12 Dec 2025 | Humanin | 5.0 | 2mg | 1.7mg | -13.1% | 98.25% | Lab D |
| 5 Dec 2025 | 1-Benzyl-4-piperidone CAS 3612-20-2 | 5.5 | 10g | 10.4g | +4.1% | 96.73% | Lab B |
| 5 Dec 2025 | MT-1 | 4.0 | 15mg | 17.9mg | +19.4% | 98.33% | Lab F |
| 23 Nov 2025 | Tirzepatide Oral | 5.2 | 20mg | 20.3mg | +1.4% | 99.35% | Lab G |
| 17 Nov 2025 | Lipo-C 120mg | 7.2 | 300mg/ml | 279.1mg/ml | -7.0% | 99.18% | Lab F |
| 14 Nov 2025 | BPC157 5mg + TB500 5mg Blend | 4.1 | 2mg | 2.4mg | +17.9% | 97.61% | Lab E |
| 14 Nov 2025 | Prostamax | 5.8 | 15mg | 15.0mg | +0.1% | 97.06% | Lab G |
| 14 Nov 2025 | Winstrol (Stanozolol) | 8.5 | 100mg | 105.1mg | +5.1% | 99.35% | Lab B |
| 4 Nov 2025 | Liraglutide | 8.2 | 20mg | 23.8mg | +19.0% | 97.78% | Lab D |
| 4 Nov 2025 | Telmisartan | 5.8 | 25mg | 26.6mg | +6.2% | 99.45% | Lab C |
| 23 Oct 2025 | Retatrutide | 4.1 | 10mg | (no batch claim) | 7.85mg | -21.5% | White Label / Silver Crimp / Clear Blue Cap |
| 17 Oct 2025 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 5.8 | 10mg | 9.3mg | -6.8% | 97.20% | Lab F |
| 17 Oct 2025 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 4.4 | 5mg | 4.5mg | -10.5% | 97.42% | Lab C |
| 9 Oct 2025 | NAD+ | 4.9 | 2mg | 1.9mg | -3.2% | 96.22% | Lab G |
| 3 Oct 2025 | Proviron (Mesterolone) | 4.0 | 25mg | 22.2mg | -11.3% | 99.78% | Lab B |
| 16 Jul 2025 | GHK-Cu | 9.8 | 50mg | 51.1mglabel | 53.97mg | +5.6% | White Label / Silver Crimp / Blue Cap |
| 20 May 2025 | Retatrutide | 5.7 | 30mg | (no batch claim) | 25.6mg | -14.7% | No Label / Silver Crimp / Violet Cap |